Latest Networking News

AMA Group has maintained its $75 million to $80 million FY27 normalised EBITDA guidance despite subdued low-severity repair volumes in the first quarter. The update also included positive operating cash flow, a resumed dividend and record FY26 revenue.

Orthocell has recorded its strongest month of US Remplir sales since launch, with 92 units generating A$279,000 in October. The result points to improving surgeon adoption and hospital access, although one month of sales does not yet establish a durable run rate or profitability.

Activeport’s Q1 FY27 revenue rose 18% to A$1.72 million as software sales more than doubled, while a completed restructure promises A$2 million in annualised savings. The sharper growth story arrives with a pressing funding question: quarter-end cash covered only 0.7 quarters of reported operating outflows.

KTEK Aerosystems has restarted deliveries under its main production program and is targeting 150 complete airframe sets per month. But the recovery is entering its most demanding phase, with A$2.31 million of quarterly operating cash outflow and only 1.1 quarters of funding under the ASX measure.

FortifAI has launched the production-ready version of its NOL8 AI Data Plane ahead of schedule, opening the door to paid enterprise proof-of-value engagements. The ASX-listed technology company ended September with A$17.3 million in cash and no debt, but still needs to convert technical validation into contracts and revenue.

Delorean’s flagship Salisbury bioenergy plant is 90% complete and now licensed to operate, while a proposed A$20 million Westpac facility could unlock its next major project. The catch is a quarterly operating cash outflow of A$2.52 million, leaving 2.52 quarters of funding on the company’s own calculation.

Adherium delivered a fifth consecutive quarterly record for remote patient monitoring revenue, but ended September with only A$120,000 in cash after a A$3.499 million operating outflow. Post-quarter loans and an AstraZeneca milestone payment have improved near-term liquidity, although further funding remains central to the company’s plans.

Frontier Energy has moved its Waroona Renewable Energy Project into construction, while higher capacity credits lift forecast annual revenue, EBITDA and free cash flow. The next major test is financial close on up to $280 million of project debt, expected in November.

Proteomics International has begun the national rollout of its Promarker D and Promarker Eso blood tests through Healius, while a A$2 million tax incentive receipt has lifted pro forma cash to A$3.8 million. Promarker Endo also cleared an independent Oxford validation hurdle, but its commercial launch remains conditional.

Strategic Elements has moved its EdgeiQ platform closer to commercial mining pilots while Energy Ink progresses towards a system-level demonstration. The ASX-listed venture developer ended September with $3.918 million in cash and an estimated 4.32 quarters of funding at the quarter’s spending rate.

Visionflex ended the September quarter with A$657,000 in cash and estimated funding for just 2.1 quarters, while aged care subscription losses drove a 25% fall in reported ARR. Revenue edged higher and costs improved, but the company now needs hardware wins to become recurring income before liquidity tightens further.

OpenLearning reached record SaaS ARR of A$3.44 million after securing more than A$2.8 million in minimum contract value during the quarter. But with only A$204,000 in cash and reported funding of 0.31 quarters, the ASX-listed education software company is preparing an entitlement issue and exploring a placement.